Ofirmev Analgesic Acetaminophen 1000mg/100mL Vial, Each

Ofirmev Analgesic Acetaminophen 1000mg/100mL Vial, Each

Marsoni

M251S

$14.98

Get it in 3 business days with 1 day shipping. Friday, May 29

Ofirmev Analgesic Acetaminophen 1000mg/100mL Vial, EachOfirmev Analgesic Acetaminophen injection is indicated for the management of mild to moderate pain; the management of moderate to severe pain with adjunctive opioid analgesics; and the reduction of fever. Sandoz Preservative Free 1000mg 100mL Intravenous Injection Single Dose Vial NDC 00781315695 License Authorization Form Required This product is a prescription drug which requires a Medical Director or Pharmacist in Charge to authorize any purchases

Easy Shipping

Quick Dispatch:

Your Ofirmev Analgesic Acetaminophen 1000mg/100mL Vial, Each orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your Ofirmev Analgesic Acetaminophen 1000mg/100mL Vial, Each ships.

Need Help?
Questions about Ofirmev Analgesic Acetaminophen 1000mg/100mL Vial, Each, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for Ofirmev Analgesic Acetaminophen 1000mg/100mL Vial, Each in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

Well it was delivered quick, and all my socks are mostly under armour, as they have developed holes in the heels now, so here i am getting a new set. they fit great, comfortable as usual. some folks may have some sort of issues, while some dont and i cannot complain. worth buying for sure. i recommend

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on April 22, 2025